drugset / Trial / NCT03127956
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris
Timeline
- Start
- 2017-03-21
- Primary completion
- 2018-04-27
- Completion
- 2018-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olumacostat Glasaretil | Small molecule | 5 % | Topical |